You are hereHome SectorsAlgeria
Misonix announces new distribution agreement for Algeria
Source: BI-ME , Author: Posted by BI-ME staff
Posted: Fri November 18, 2011 12:33 pm

INTERNATIONAL.  Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical applications, has entered into a new, two year, exclusive distribution agreement with SARL EXCELLENCE SANTE (SES) of Algiers, Algeria for the distribution of the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpelâ„¢ Ultrasonic Bone Cutter. 

The agreement provides SES with the rights to sell throughout Algeria.  Included in the agreement are annual minimum purchase requirements.  Initial product training is complete and open market sales are underway.
 
SES is a respected distributor of state-of-the-art medical devices and has successfully launched multiple new products into Algeria, including capital equipment-based surgical systems, and is well known for their commitment to service and physician training, particularly in the fields of Spine Surgery, Orthopedic Surgery and Neurosurgery.
 
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels.  In addition, OsteoSculptâ„¢ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
 
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.  It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.
 
"Misonix is very pleased to have SES become our third distributor for emerging markets on the African continent.  Their reputation as a quality distributor of advanced medical equipment has been established," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.  "Their commitment to clinical education and service matches Misonix's own values in these areas.  We are particularly pleased that they will be selling two of our key products throughout Algeria."
 
About Misonix:

Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices.  Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies.  Addressing a combined market estimated to be in excess of US$3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. 

Additional information is available on the Company's Web site at www.misonix.com.

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: July 29, 2014
KUWAIT. US$35.1 billioln of new sukuks issued during 2Q14; GCC primary market account for 26.7% market share or US$17.7 billion of the total global new sukuk issuances in 1H14.
date:Posted: July 28, 2014
INTERNATIONAL. Janet Yellen is very different from any of her predecessors. She is likely the most dovish and politically leftist Fed Chair in the Central Bank's history; She sees the Fed's mission as a tool to promote progressive social policy.
date:Posted: July 28, 2014
QATAR. The potential in Indonesia is enormous and more rapid growth could generate opportunities for a number of foreign companies, says QNB Group report.
INTERNATIONAL. Another sign of deteriorating relations between the United States and Russia; The Cold War treaty, ratified in 1988, was designed to eliminate ground-launched cruise missiles with ranges of 500 to 5,500 km.
dhgate